Skip to main content
. 2018 May 4;10:977–988. doi: 10.2147/CMAR.S161398

Table 1.

Comparison of demographic, clinicopathologic, and laboratory data in cirrhosis- and noncirrhosis HCC groups

Variables Total, n=109 Cirrhosis group, n=62 Noncirrhosis group, n=47 p
Age (years), median (range) 66 (18–82) 66 (42–82) 65 (18–80) 0.070
Sex, n (%)
 Male 65 (59.6) 35 (56.5) 30 (63.8) 0.437
 Female 44 (40.4) 27 (43.5) 17 (36.2
ASA, n (%)
 I/II 62 (56.9) 32 (51.6) 30 (63.8) 0.202
 III/IV 47 (43.1) 30 (48.4) 17 (36.2)
Etiology, n (%)
 HBV 30 (27.5) 30 (27.5)
 HCV 23 (21.1) 23 (21.1)
 Alcohol abuse 6 (5.5) 6 (5.5)
 Other (unknown) 3 (2.8) 3 (2.8)
 Liver steatosis 17 (15.6) 17 (36.2)
 Alcohol excess 2 (1.8) 2 (4.2)
 Adenoma alteration 5 (4.6) 5 (10.6)
WBC (×109/L), median (range) 6.7 (2–11) 6.5 (2–10) 7 (4–11) 0.662
Platelet (×109/L), median (range) 210 (42–583) 210 (42–427) 218 (123–583) 0.158
NLR, median (range) 1.95 (0.37–6.07) 2.04 (0.63–6.07) 1.74 (0.37–5.78) 0.520
PLR, median (range) 107.5 (11.2–647.8) 107.5 (20.1–266.9) 98.4 (11.2–647.8) 0.343
Total bilirubin (mmol/L), median (range) 12.5 (3.8–636) 15 (3.8–636) 11 (4–26) 0.149
ALT (IU/L), median (range) 32 (6–166) 35 (6–166) 29 (11–158) 0.311
γGT (IU/L), median (range) 59 (9–1185) 68.5 (9–1185) 53 (10–871) 0.490
Lesion number, n (%)
 Single 95 (87.2) 52 (83.9) 43 (91.5) 0.239
 Multiple 14 (12.8) 10 (16.1) 4 (8.5)
Major lesion size, n (%)
 <5 cm 12 (11) 7 (11.3) 5 (10.6) 0.914
 ≥5 cm 97 (89) 55 (88.7) 42 (89.4)
Operative time (min), median (range) 240 (55–600) 240 (55–600) 300 (120–480) 0.373
Transection time (min), median (range) 60 (15–210) 60 (15–210) 60 (15–210) 0.745
Hepatectomy, n (%)
 Anatomic 52 (47.7) 29 (46.8) 23 (48.9) 0.823
 Nonanatomic 57 (52.3) 33 (53.2) 24 (51.1)
Extent of resection, n (%)
 Major 39 (35.8) 20 (32.3) 19 (40.4) 0.378
 Minor 70 (64.2) 42 (67.7) 28 (59.6)
Intraoperative transfusion rate, n (%) 7 (6.4) 2 (3.2) 5 (10.6) 0.235

Abbreviations: γGT, gamma-glutamyl transferase; ALT, alanine aminotransferase; ASA, American Society of Anesthesiologists; HBV, hepatitis B virus; HCC, hepatocellular cancer; HCV, hepatitis C virus; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet to lymphocyte ratio; WBC, white blood cells.